12 titres de soins de sant en mouvement lors de la session apr s-cl ture le 09/04/2024Benzinga • 16 days ago
Gagnants
Le titre IN8bio (NASDAQ:INAB) a augment mardi de 31,19% 1,43 dollars lors de la session after-market.
L'action ImmuCell (NASDAQ:ICCC) a grimp de 11,11% 5,80 dollars.
L'action aTyr...
Share to Feed
SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its...
Related Stocks: NAS:LIFE...
aTyr Pharma, Inc. (LIFE) Q4 2023 Earnings Call Transcript...
Enrollment for Phase 3 EFZO-FIT Study Advances with Strong Cash PositionRelated Stocks: LIFE...
Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis anticipated to complete enrollment in the second quarter of 2024. Company launches Individual Patient Expanded Access Program...
Key Insights Given the large stake in the stock by institutions, aTyr Pharma's stock price might be vulnerable to their...
Management to host conference call and webcast on March 14th at 5:00 pm EDT / 2:00 pm PDTSAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage...
Individual Patient EAP allows access to efzofitimod for patients who complete the Phase 3 EFZO-FIT study in pulmonary sarcoidosis. Company initiating program based on blinded EFZO-FIT study...
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...